Scientists have developed novel specific tests to spot cancer biomarkers in patients with dermatomyositis - a systemic inflammatory disease associated with increased risk of malignancy. According to study findings published in the American College of Rheumatology (ACR) journal, iArthritis (and) Rheumatism/i, the assays detect antibodies against anti-transcriptional intermediary factor-1 (TIF-1 (and) #947;) and nuclear matrix protein NXP-2. Patients with dermatomyositis ...Monday, 2 September 2013
New Tests to Identify Cancer Biomarkers in Dermatomyositis Developed
Scientists have developed novel specific tests to spot cancer biomarkers in patients with dermatomyositis - a systemic inflammatory disease associated with increased risk of malignancy. According to study findings published in the American College of Rheumatology (ACR) journal, iArthritis (and) Rheumatism/i, the assays detect antibodies against anti-transcriptional intermediary factor-1 (TIF-1 (and) #947;) and nuclear matrix protein NXP-2. Patients with dermatomyositis ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment